Your Best Stock
Stocks › DHR

Danaher DHR

US equityMarket cap rank #102Diagnostics & Research
$222.70
+$1.14 (+0.51%)
Market open · Sep 24, 2:00 pm ET
After hours $221.55 0.00%
Open$220.00
Prev close$221.56
Day range$219.00 – $226.64
Volume3.21M
Market cap$156.55B
P/E (TTM)39.6
Dividend yield0.65%

Earnings

Average move on report day±4.9%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+7.2%
Worst reaction-11.0%

Stock move on the day after each report

-3.5%2023/Q3+4.7%2023/Q4+7.2%2024/Q1+5.3%2024/Q2-4.0%2024/Q3-9.7%2024/Q4+3.8%2025/Q1+1.0%2025/Q2+5.9%2025/Q3-4.8%2025/Q4-0.5%2026/Q1-11.0%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q221 Jul 2026Pre Market±13.0%-10.99%Within range
2026/Q121 Apr 2026Pre Market±9.3%-0.49%Within range
2025/Q428 Jan 2026Pre Market±10.5%-4.76%Within range
2025/Q321 Oct 2025Pre Market±13.2%+5.94%Within range
2025/Q222 Jul 2025Pre Market±10.8%+0.98%Within range
2025/Q122 Apr 2025Pre Market±12.7%+3.84%Within range
2024/Q429 Jan 2025Pre Market±11.8%-9.73%Within range
2024/Q322 Oct 2024Pre Market±13.8%-3.97%Within range
2024/Q223 Jul 2024Pre Market±12.7%+5.30%Within range
2024/Q123 Apr 2024Pre Market±11.2%+7.21%Within range
2023/Q430 Jan 2024Pre Market±10.1%+4.71%Within range
2023/Q324 Oct 2023Pre Market±9.2%-3.53%Within range
2023/Q225 Jul 2023Pre Market±13.0%-0.88%Within range
2023/Q125 Apr 2023Pre Market±9.7%-8.79%Within range
2022/Q424 Jan 2023Pre Market±12.4%-1.96%Within range
2022/Q320 Oct 2022Pre Market±12.0%-5.74%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Diagnostics$2.47B 39.4%
  • Biotechnology$1.92B 30.6%
  • Life sciences$1.88B 30.0%

Latest reported quarter: Q2, ended Jun 2026

Revenue$6.27B+5.5% YoY
Operating profit$1.13B+48.3% YoY
Net profit$870.00M+56.8% YoY
Diluted EPS$1.23+59.7% YoY
Free cash flow$1.27B+16.1% YoY
Operating cash flow$1.53B

Revenue, last 8 quarters

$5.8BSep '24$6.5BDec '24$5.7BMar '25$5.9BJun '25$6.1BSep '25$6.8BDec '25$6.0BMar '26$6.3BJun '26

Net profit, last 8 quarters

$818.0MSep '24$1.1BDec '24$954.0MMar '25$555.0MJun '25$908.0MSep '25$1.2BDec '25$1.0BMar '26$870.0MJun '26

Profitability & balance sheet

Gross margin58.5%
Operating margin20.4%
Net margin15.9%
Return on equity7.6%
Return on assets4.6%
Return on invested capital5.6%
Current ratio1.65
Liabilities / assets43.1%
Cash & investments$4.35B
Total debt$26.56B
Net cash (debt)-$22.21B
Free cash flow / sales21.8%
Scroll to Top